BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Change in the Number of Shares Outstanding in Sectra (SECTB)


6/29/2012 10:07:58 AM

LINKÖPING, Sweden--(BUSINESS WIRE)--Regulatory News:

As at June 29, 2012, the share capital in Sectra AB (NASDAQ OMX Stockholm: SECT B) amounts to SEK 37,094,978 – represented by 37,094,978 shares – of which 2,620,692 are Series A and 34,474,286 are Series B shares. This entails an increase of 252,890 Series B shares in the number of shares outstanding during June.

The change is attributable to an issue of shares in connection with conversion of the convertible debentures that had been issued to employees and non-executive Board members in 2009.

The information in this press release is such that Sectra AB (publ) is obligated to disclose in compliance with the Swedish Securities and Clearing Operations Act. The information was submitted for publication on June 29, 2012, at 9:00 (CET).


Read at BioSpace.com

Sectra
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->